EP1755596
Aðferð til að gera atazanavir bísúlfat og ný form
Status:
EP Einkaleyfi útrunniðEP appl. date:
3.5.2005EP published:
12.8.2015EP application number:
05744537.1
EP translation filed:
29.10.2015Grant published:
15.11.2015EPO information:
European Patent Register
Max expiry date:
2.5.2025Expiry date:
2.5.2025
Title:
PROCESS FOR PREPARING ATAZANAVIR BISULFATE AND NOVEL FORMS
Timeline
Today
3.5.2005EP application
12.8.2015EP Publication
29.10.2015Translation submitted
15.11.2015Registration published
2.5.2025Expires
Owner
Name:
Bristol-Myers Squibb Holdings Ireland Unlimited CompanyAddress:
Hinterbergstrasse 16, 6312, Steinhausen, CH
Inventor
Name:
KIM, SoojinAddress:
Demarest, NJ, US
Name:
LOTZ, Bruce, T.Address:
Yardville, NJ, US
Name:
MALLEY, Mary, F.Address:
Lawrenceville, NJ, US
Name:
GOUGOUTAS, Jack, Z.Address:
Princeton, NJ, US
Name:
DAVIDOVICH, MarthaAddress:
East Brunswick, NJ, US
Name:
SRIVASTAVA, Sushil, K.Address:
Dayton, NJ, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
568043 PDate:
4.5.2004Country:
US
Number:
607533 PDate:
7.9.2004Country:
US
Number:
119558Date:
2.5.2005Country:
US
Classification
Categories:
C07D 213/56, A61K 31/44
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 12.4.2016
Expires: 2.5.2017
Payer: Árnason Faktor
Number: 13
Paid: 10.4.2017
Expires: 2.5.2018
Payer: Árnason Faktor
Number: 14
Paid: 9.4.2018
Expires: 2.5.2019
Payer: Árnason Faktor
Number: 15
Paid: 5.4.2019
Expires: 2.5.2020
Payer: Árnason Faktor
Number: 16
Paid: 7.4.2020
Expires: 2.5.2021
Payer: Árnason Faktor ehf.
Number: 17
Paid: 8.4.2021
Expires: 2.5.2022
Payer: Árnason Faktor ehf.
Number: 18
Paid: 5.4.2022
Expires: 2.5.2023
Payer: Árnason Faktor ehf.
Number: 19
Paid: 12.4.2023
Expires: 2.5.2024
Payer: Árnason Faktor ehf.
Number: 20
Paid: 5.4.2024
Expires: 2.5.2025
Payer: Árnason Faktor ehf.